Five new studies span three focus areas for LTCM devices: digital engagement and patient satisfaction, arrhythmia patterns during sleep and activity, and the potential health care resource and economic impact of early arrhythmia detection in patients with type 2 diabetes and COPD
SAN FRANCISCO, Nov. 18, 2024 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the results of five new studies presented at the American Heart Association’s 2024 Scientific Sessions in Chicago, IL. The findings underscore iRhythm’s commitment to advancing ambulatory cardiac monitoring services to improve patient outcomes, enhance healthcare resource utilization, and provide access to affordable care, including for patients with chronic conditions.
The five studies presented by iRhythm span three focus areas for long-term continuous monitoring (LTCM): patient engagement and satisfaction through digital tools and patient-centered product enhancements, evaluating arrhythmia patterns during periods of sleep and activity, and assessing the potential healthcare resource and economic impact of early arrhythmia detection in patients with type 2 diabetes and chronic obstructive pulmonary disease (COPD).
“These new findings underscore iRhythm’s commitment to rigorous scientific evidence,” said Mintu Turakhia, MD, iRhythm’s Chief Medical (TASE:) and Scientific Officer and EVP of Product Innovation. “Our data demonstrates the significant health economic benefits of early arrhythmia detection in often-overlooked conditions like diabetes and COPD, highlights greater patient engagement through our patient-centered digital tools that complement our services, and reveals distinct arrhythmia patterns associated with sleep and activity.”
LTCM Patient Engagement and Satisfaction Through Digital Tool and Product Enhancements
Two studies validated the impact of digital health tools on improving patient compliance with timely device return and demonstrate the value of using patient-centric feedback to guide enhancements in the latest Zio ® monitor.
- Digital Engagement With a Patient Smartphone App and Text Messaging is Associated with Increased Compliance in Patients Undergoing Long-Term Continuous Ambulatory Cardiac Monitoring
- Feasibility of Point-Of-Wear Patient Satisfaction Surveys to Validate Patient-Centered Product Enhancements: Results From Over 300,000 Patients for Long-Term Ambulatory Cardiac Monitoring
Evaluating Sleep and Activity Arrhythmia Patterns Using…
Click Here to Read the Full Original Article at All News…
